Ossity is our latest product. It's a search hub and web research tool. Try it now for free!

This page has been Textised!
The original page address was https://calpgen.com/
For sharing use (TinyUrl conversion failed)

Here are some options:

- Back to original page (in this window | in a new window)
- Convert this page to a PDF
- Print this page
- Textise Home Page (full version | text only version)
- Textise Options Page (choose font size, font colour, etc.)

Are you a webmaster? Find out how to easily add Textise to your web site.

Skip to content
Full 1
We target proteases and discover novel therapeutic antibodies.
[Image: Full 1]  
Full 3
Reagents and tools
Antibodies, constructs, protocols and more...
[Image: Full 3]  
[Image: previous arrow]  
[Image: next arrow]  
Home
THERAPEUTICS
Anti-protease combination therapy currently under development to reduce recurrent strokes, inflammation, and chronic pain in patients with Sickle Cell Disease and COVID-19.

DIAGNOSTICS
Novel diagnostic assays for babesiosis and cerebral malaria are currently under development. Our technology is guided by the phage display cDNA technology and rapid immunoassays.

REAGENTS & TOOLS
Antibodies, constructs, reagents, and protocols will be shared with the scientific community.

A SiteOrigin Theme
 

Textise: Back to top
This text-only page was created by Textise (www.textise.net) © Textise - CPC LLC
To find out more about our product, visit Textise.org.